18.4
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high serop…
Toxoplasmosis is caused by the zoonotic parasite Toxoplasma gondii. It can spread to humans by eating undercooked meat that contains tissue cysts with bradyzoites.
It can also be transmitted through oocysts shed by definitive hosts such as cats.
These oocysts sporulate in the environment, contaminate the surroundings, and can infect humans when they are ingested.
After ingestion, gastric juices break down the outer cyst wall in the digestive tract. This releases sporozoites that enter the gut epithelium.
The sporozoites turn into rapidly dividing tachyzoites, which invade immune cells to spread throughout the body.
The immune cells carry tachyzoites across the blood-brain barrier. This triggers the production of interferon-gamma, which limits the growth and spread of tachyzoites.
The tachyzoites then change into slow-dividing bradyzoites.
In healthy humans, bradyzoites stay in tissues, divide slowly, and form cysts without causing disease.
If the host immune system is suppressed, these bradyzoites can rapidly turn back into tachyzoites, causing encephalitis, which is inflammation of the brain tissue.
View the full transcript and gain access to JoVE Core videos
Q1: How does Toxoplasma gondii spread to humans?
Toxoplasma gondii spreads to humans primarily through ingestion of undercooked meat containing tissue cysts with bradyzoites, or through oocysts shed by cats into the environment. These oocysts sporulate and contaminate food, water, and soil. Less common routes include vertical transmission, organ transplantation, and blood transfusion.
Q2: What happens to Toxoplasma parasites after ingestion?
After ingestion, gastric juices break down the cyst wall, releasing sporozoites that enter the gut epithelium. Sporozoites transform into rapidly dividing tachyzoites, which invade immune cells and spread throughout the body. Immune cells carry tachyzoites across the blood-brain barrier, triggering interferon-gamma production that limits parasite growth.
Q3: Why do some people with toxoplasmosis develop encephalitis?
In healthy individuals, tachyzoites transform into slow-dividing bradyzoites that form tissue cysts without causing disease. However, if the host immune system becomes suppressed—such as in HIV/AIDS or during chemotherapy—bradyzoites rapidly revert to tachyzoites, causing encephalitis, an inflammation of brain tissue.
Q4: What role do bradyzoites play in toxoplasmosis?
Bradyzoites are slow-dividing forms of Toxoplasma that develop after the acute immune response suppresses tachyzoites. They form tissue cysts primarily in neural and muscular tissues, where they may remain latent for life. Under immunosuppression, bradyzoites can reactivate and convert back into tachyzoites, causing severe disease.
Q5: How does the immune system initially control Toxoplasma infection?
When tachyzoites cross the blood-brain barrier, they trigger interferon-gamma production, which limits tachyzoite growth and spread. This immune response causes tachyzoites to differentiate into bradyzoites and form tissue cysts. In immunocompetent individuals, this containment prevents active disease, though parasites persist in latent cysts.
Q6: What are the three infectious forms of Toxoplasma gondii?
The three infectious forms are tachyzoites, bradyzoites, and sporozoites. Tachyzoites are rapidly replicating forms that disseminate infection and provoke acute immune responses. Bradyzoites are slow-dividing forms within tissue cysts, while sporozoites develop from oocysts in the environment and initiate infection upon ingestion.
Q7: How does toxoplasmosis relate to other parasitic infections in public health?
Toxoplasmosis exemplifies zoonotic parasitic diseases requiring integrated public health approaches. Like other parasitic infections such as cryptococcal meningitis, it poses particular risks to immunocompromised populations. The disease underscores the One Health framework, linking human, animal, and environmental health through food safety, sanitation, and screening strategies.